FCD105
FX2016-40
Phase 2 other completed
Quick answer
FCD105 for Acne Vulgaris is a Phase 2 program (other) at VYNE Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- VYNE Therapeutics
- Indication
- Acne Vulgaris
- Phase
- Phase 2
- Modality
- other
- Status
- completed